AstraZeneca Aktie
173,65
EUR
+2,45
EUR
+1,43
%
205,55
USD
+1,03
USD
+0,50
%
Werbung
AstraZeneca Aktie Analyse
| 31.03.20 | AstraZeneca buy | Oddo BHF | |
| 20.03.20 | AstraZeneca buy | Deutsche Bank AG | |
| 17.03.20 | AstraZeneca overweight | Barclays Capital | |
| 09.03.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 25.02.20 | AstraZeneca buy | Deutsche Bank AG | |
| 18.02.20 | AstraZeneca buy | Kepler Cheuvreux | |
| 17.02.20 | AstraZeneca buy | Deutsche Bank AG | |
| 17.02.20 | AstraZeneca Outperform | Credit Suisse Group | |
|
Werbung
|
|||
| 14.02.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 14.02.20 | AstraZeneca overweight | Barclays Capital | |
| 05.02.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 31.01.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 28.01.20 | AstraZeneca buy | Deutsche Bank AG | |
| 16.01.20 | AstraZeneca overweight | Barclays Capital | |
| 16.01.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 06.01.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 17.12.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 12.12.19 | AstraZeneca buy | Deutsche Bank AG | |
| 22.11.19 | AstraZeneca overweight | Barclays Capital | |
| 12.11.19 | AstraZeneca buy | Deutsche Bank AG | |
| 11.11.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 08.11.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 07.11.19 | AstraZeneca buy | Deutsche Bank AG | |
| 30.10.19 | AstraZeneca buy | Deutsche Bank AG | |
| 29.10.19 | AstraZeneca buy | Kepler Cheuvreux | |
| 29.10.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.10.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 25.10.19 | AstraZeneca buy | Deutsche Bank AG | |
| 25.10.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 24.10.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 22.10.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 14.10.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 08.10.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 30.09.19 | AstraZeneca buy | Deutsche Bank AG | |
| 20.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 16.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 13.09.19 | AstraZeneca buy | Merrill Lynch & Co., Inc. | |
| 13.09.19 | AstraZeneca overweight | Barclays Capital | |
| 09.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.09.19 | AstraZeneca buy | Deutsche Bank AG | |
| 06.09.19 | AstraZeneca overweight | Barclays Capital | |
| 05.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 02.09.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 28.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 21.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 20.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 16.08.19 | AstraZeneca overweight | Barclays Capital | |
| 14.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.08.19 | AstraZeneca overweight | Barclays Capital | |
| 09.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
Werbung
Werbung